Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats. Course of development and effects of insulin treatment

Brain

Volumn 122, Issue 4, 1999, Pages 757-768

  Biessels, Geert Jan ^a,b   Cristino, Nuno A ^a   Rutten, Geert Jan ^a   Hamers, Frank P T ^a   Erkelens, D Willem ^b   Gispen, Willem Hendrik ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Diabetes mellitus; Evoked potentials; Insulin; Nerve conduction; Spinal cord

Indexed keywords

INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE COURSE; EVOKED AUDITORY RESPONSE; EVOKED VISUAL RESPONSE; INSULIN TREATMENT; LATENT PERIOD; MALE; NERVE CONDUCTION; NEUROPHYSIOLOGY; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SPINAL CORD; STREPTOZOCIN DIABETES; VELOCITY;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; HYPOGLYCEMIC AGENTS; INSULIN; LONGITUDINAL STUDIES; MALE; NEURAL CONDUCTION; NEURONS, AFFERENT; RATS; RATS, WISTAR; SCIATIC NERVE; SPINAL CORD;

EID: 0032899849     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/122.4.757     Document Type: Article

References (46)

1. Apaydin C, Oguz Y, Agar A, Yargicoglu P, Demir N, Aksu G. Visual evoked potentials and optic nerve histopathology in normal and diabetic rats and effect of ginkgo biloba extract. Acta Ophthalmol (Copenh) 1993; 71: 623-8.
2. Araki Y, Nomura M, Tanaka H, Yamamoto H, Yamamoto T, Tsukaguchi I, et al. MRI of the brain in diabetes mellitus. Neuroradiology 1994; 36: 101-3.
3. Arezzo JC. The use of electrophysiology for the assessment of diabetic neuropathy. Neurosci Res Commun 1997; 21: 13-23.
4. Barth DS, Goldberg N, Brett B, Di S. The spatiotemporal organization of auditory, visual, and auditory-visual evoked potentials in rat cortex. Brain Res 1995; 678: 177-90.
5. Biessels GJ, Rappelle AC, Bravenboer B, Erkelens DW, Gispen WH. Cerebral function in diabetes mellitus (see comments]. [Review]. Diabetologia 1994; 37: 643-50. Comment in: Diabetologia 1995; 38: 251-2, Comment in: Diabetologia 1995; 38: 1004-5.
6. Biessels GJ, Rappelle AC, Bravenboer B, Erkelens DW, Gispen WH. Cerebral function in diabetes mellitus (see comments]. [Review]. Diabetologia 1994; 37: 643-50. Comment in: Diabetologia 1995; 38: 251-2, Comment in: Diabetologia 1995; 38: 1004-5.
7. Biessels GJ, Rappelle AC, Bravenboer B, Erkelens DW, Gispen WH. Cerebral function in diabetes mellitus (see comments]. [Review]. Diabetologia 1994; 37: 643-50. Comment in: Diabetologia 1995; 38: 251-2, Comment in: Diabetologia 1995; 38: 1004-5.
8. Brismar T, Sima AA, Greene DA. Reversible and irreversible nodal dysfunction in diabetic neuropathy. Ann Neurol 1987; 21: 504-7.
9. Buller N, Laurian N, Shvili I, Laurian L. Delayed brainstem auditory evoked responses in experimental diabetes mellitus. J Laryngol Otol 1986; 100: 883-91.
10. Cameron NE, Cotter MA. The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. [Review]. Diabetes Metab Rev 1994; 10: 189-224.
11. Cameron NE, Cotter MA, Harrison J. Effect of diabetes on motor conduction velocity in different branches of the rat sciatic nerve. Exp Neurol 1986; 92: 757-61.
12. Garsten RE, Whalen LR, Ishii DN. Impairment of spinal cord conduction velocity in diabetic rats. Diabetes 1989; 38: 730-6.
13. De Koning P, Gispen WH. Org.2766 improves functional and electrophysiological aspects of regenerating sciatic nerve in the rat. Peptides 1987; 8: 415-22.
14. Dejgaard A, Gade A, Larsson H, Balle V, Parving A, Parving HH. Evidence for diabetic encephalopathy. Diabet Med 1991; 8: 162-7.
15. Di Mario U, Morano S, Valle E, Pozzessere G. Electrophysiological alterations of the central nervous system in diabetes mellitus. [Review]. Diabetes Metab Rev 1995; 11: 259-77.
16. Duckrow RB, Beard DC, Brennan RW. Regional cerebral blood flow decreases during chronic and acute hyperglycemia. Stroke 1987; 18: 52-8.
17. Engerman RL, Kern TS. Retinopathy in animal models of diabetes. [Review]. Diabetes Metab Rev 1995; II: 109-20.
18. Fehlings MG, Tator CH, Linden RD, Piper IR. Motor and somatosensory evoked potentials recorded from the rat. Electroencephalogr Clin Neurophysiol 1988; 69: 65-78.
19. Funai H, Funasaka S. Experimental study on the effect of inferior colliculus lesions upon auditory brain stem response. Audiology 1983; 22: 9-19.
20. Greene DA, Lattimer SA. Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation. J Clin Invest 1983; 72: 1058-63.
21. Halliday AM, Kriss A. The visual evoked potential and electroretinogram in the investigation of diseases of the eye. In: Halliday AM, editor. Evoked potentials in clinical testing. 2nd ed. Edinburgh: Churchill Livingstone; 1993. p. 141-93.
22. Jakobsen J, Nedergaard M. Aarslew-Jensen M, Diemer NH. Regional brain glucose metabolism and blood flow in streptozotocin-induced diabetic rats. Diabetes 1990; 39: 437-40.
23. 2+ antagonist, nimodipine, of an existing neuropathy in the streptozotocin-induced, diabetic rat. Br J Pharmacol 1993; 108: 780-5.
24. 2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor rat. Br J Pharmacol 1994; 111: 887-93.
25. Knudsen GM, Jakobsen J, Barry DI, Compton AM, Tomlinson DR. Myo-inositol normalizes decreased sodium permeability of the blood-brain barrier in streptozotocin diabetes. Neuroscience 1989; 29: 773-7.
26. Kumar JS, Menon VP. Effect of diabetes on levels of lipid peroxides and glycolipids in rat brain. Metabolism 1993; 42: 1435-39.
27. Kuypers HGJM. Anatomy of the descending pathways. In: Brookhart TM, Mountcastle VB, editors. Handbook of physiology, Sect. 1; Vol. 2, Pt 1. Bethesda (MD): American Physiological Society; 1981. p. 597-666.
28. Moore SA, Peterson RG, Felten DL. O'Connor BL. A quantitative comparison of motor and sensory conduction velocities in short- and long-term streptozotocin- and alloxan-diabetic rats. J Neurol Sci 1980; 48: 133-52.
29. Morano S, Sensi M, Di Gregorio S, Pozzessere G, Petrucci AF, Valle E, et al. Peripheral, but not central, nervous system abnormalities are reversed by pancreatic islet transplantation in diabetic Lewis rats. Eur J Neurosci 1996; 8: 1117-23.
30. Notvest RR, Inserra JJ. Tolrestat, an aldose reductase inhibitor, prevents nerve dysfunction in conscious diabetic rats. Diabetes 1987; 36: 500-4.
31. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. San Diego (CA): Academic Press; 1986.
32. Rubini R, Biasiolo F, Fogarolo F, Magnavita V, Martini A, Fiori MG. Brainstem auditory evoked potentials in rats with streptozotocin-induced diabetes. Diabetes Res Clin Pract 1992; 16: 19-25.
33. Schwarz M, Block F. Visual and somatosensory evoked potentials are mediated by excitatory ammo acid receptors in the thalamus. Electroencephalogr Clin Neurophysiol 1994; 91: 392-8.
34. Shaw NA. The auditory evoked potential in the rat - a review. [Review]. Prog Neurobiol 1988; 31: 19-45.
35. Sima AA, Zhang WX, Cherian PV, Chakrabarti S. Impaired visual evoked potential and primary axonopathy of the optic nerve in the diabetic BB/W-rat. Diabetologia 1992; 35: 602-7.
36. Stevens EJ, Carrington AL, Tomlinson DR. Nerve ischaemia in diabetic rats: time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models. Diabetologia 1994; 37: 43-8.
37. Terada M, Yasuda H, Kikkawa R, Koyama N, Yokota T, Shigeta Y. Electrophysiological study of dorsal column function in streptozotocin-induced diabetic rats: comparison with 2,5-hexanedione intoxication. J Neurol Sci 1993; 115: 58-66.
38. Thomas PK, Tomlinson DR. Diabetic and hypoglycemic neuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, editors. Peripheral neuropathy. 3rd ed. Philadelphia: W.B. Saunders: 1993. p. 1219-50.
39. Tuck RR, Schmelzer JD, Low PA. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 1984; 107: 935-50.
40. Tun PA, Nathan DM, Perlmuter LC. Cognitive and affective disorders in elderly diabetics. [Review]. Clin Geriatr Med 1990; 6: 731-46.
41. van de Meent H, Hamers FP, Lankhorst AJ, Buise MP, Joosten EA, Gispen WH. New assessment techniques for evaluation of posttraumatic spinal cord function in the rat. J Neurotrauma 1996; 13: 741-54.
42. Wada SI, Starr A. Generation of auditory brain stem responses (ABRs). III. Effects of lesions of the superior olive, lateral lemniscus and inferior colliculus on the ABR in guinea pig. Electroencephalogr Clin Neurophysiol 1983; 56: 352-66.
43. Wright RA, Nukada H. Vascular and metabolic factors in the pathogenesis of experimental diabetic neuropathy in mature rats. Brain 1994; 117: 1395-1407.
44. Yagihashi S. Pathology and pathogenetic mechanisms of diabetic neuropathy. [Review]. Diabetes Metab Rev 1995; 11: 193-225.
45. Yildiz O, Özata M, Özkardes A, Çorakçi A, Gündogan N, Gündogan MA. L-carnitine treatment improves brain stem auditory evoked potentials in diabetic rats. Neuroreport 1996; 7: 2957-9.
46. Zappulla RA, Hollis P, Ryder J, Moore FM, Adamson J, Moustakis W, et al. Noncortical origins of the spinal motor evoked potential in rats. Neurosurgery 1988; 22: 846-52.